Monthly Archives: July 2022

It’s the Home Stretch!

Posted on July 18, 2022 by melelllan

ACADIA has announced the submission of Trofinetide’s application to the FDA! The words we have been waiting for have finally been written. It’s a couple of weeks later than our hearts were shooting for, but better late and the best … Continue reading →

Posted in Acadia, Daffodil trial, FDA, LAVENDER TRIAL, Neuren, NNZ-2566 trial, orphan drug designation, Rett Research, Rett Syndrome, Trail to a Texas Trial, Trofinetide, Trofinetide Pediatric trial, Trofinetide Phase III, Uncategorized | 2 Comments